FOOT & ANKLE
Achilles tendinosis: No difference in clinical outcomes with various injectable treatments
Foot Ankle Int. 2013 May;34(5):619-28. doi: 10.1177/1071100713475353. Epub 2013 Feb 4Nine randomized controlled trials examining the effects of either platelet-rich plasma (PRP), autologous blood injections, sclerosing agents, protease inhibitors, deproteinized hemodialystate, corticosteroids or prolotherapy in the treatment of non-insertional Achilles tendinosis were selected for this review. The purpose of this review was to summarize the effectiveness of various injectable treatments in the management of non-insertional Achilles tendinosis. Results indicated that mild to moderate improvements in clinical outcomes were found with the use of various injectable treatments, however this improvement was not significantly different when compared to the control/placebo group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
